Equal protection under the law.
Except for rationed lifesaving covid drugs, like
monoclonals
“The Food and Drug Administration is urging health care providers to consider race or ethnicity as well as underlying medical conditions when classifying individuals as “high risk for progression to severe COVID-19″ and qualifying for antibody treatment.
A fact sheet issued by the agency detailing the emergency use authorization of the drug sotrovimab for treatment of mild to moderate COVID-19 cases includes a list of medical conditions that may qualify patients for the treatment.”
nypost.com/2022/01/10/fda-wants-race-ethnicity-factored-in-administering-covid-drugs/
h/t dodger007
Views: